Publications & Presentations

Our Directors have contributed extensively to industry knowledge through publications and presentations at prominent national and international conferences.

They regularly share insights on key topics, such as market access strategies, early engagement, and healthcare technology assessments, reflecting HEARS’ commitment to thought leadership and innovation in the pharmaceutical and healthcare sectors.

  • Szoeke C, Phillips S, Downie S, Campbell S. Hormones and dementia. In: Ferretti MT, Schumacher Dimech A, Santuccione A, editors. Sex and Gender Differences in Alzheimer's Disease. [Elsevier].

  • Ramagopalan, S. V., Jullien Pannelay, A., & Atkins, J. (2025). Access in all areas? A round-up of developments in market access and health technology assessment: part 11 Industry Update. Journal of Comparative Effectiveness Research, Advance online publication.  https://doi.org/10.57264/cer-2025-0176

    Szoeke C, Phillips S, Downie S, Parker A, Chin TJ. Sex hormones, vascular factors and cognition. Front Neuroendocrinol. 2021;62:100927. doi:10.1016/j.yfrne.2021.100927

    Van Bellinghen LA, Dimitroff A, Haberl M, Li X, Manton A, Moeremans K, et al. Is adding maternal vaccination to prevent whooping cough cost-effective in Australia? Hum Vaccin Immunother. 2018;14(9):2263–2273. doi:10.1080/21645515.2018.1474315

    Jamotte A, Chong CF, Manton A, Macabeo B, Toumi M. Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia. BMC Public Health. 2016;16:630. doi:10.1186/s12889-016-3297-1

    Kral P, Allen FL, Larsen S, Holst-Hansen T, Olivieri AV, Manton A. Treatment effect of semaglutide 2.4 mg on health-related quality of life from STEP 1 SF-6D derived from SF-36 with Australian weights. Diabetes Obes Metab. 2024;26(4):1171–1179. doi:10.1111/dom.15426

    Garrett SK, McNeil JJ, Silagy C, Sinclair M, Thomas AP, Robman LP, et al. Methodology of the VECAT study: vitamin E intervention in cataract and age-related maculopathy. Ophthalmic Epidemiol. 1999;6(3):195–208.

    Garrett SK, Thomas AP, Cicuttini F, Silagy C, Taylor HR, McNeil JJ. Community-based recruitment strategies for a longitudinal interventional study: the VECAT experience. J Clin Epidemiol. 2000;53(5):541–8.

    Robman LD, McCarty CA, Garrett SK, Maclean H, McNeil JJ, Taylor HR. Variability in digital assessment of cortical and posterior subcapsular cataract. Ophthalmic Res. 1999;31(2):110–8.

  • Szoeke C, Golding C, Phillips S, Zanker J. From aged care crisis to healthy ageing community. *MJA Insight*. 2020 Nov 16. Available from: https://insightplus.mja.com.au/2020/45/from-aged-care-crisis-to-healthy-ageing-community/

    Szoeke C, Golding C, Phillips S, Zanker J. Transforming the aged care crisis. *Pursuit*. 2020 Nov 16. Available from: https://pursuit.unimelb.edu.au/articles/transforming-the-aged-care-crisis

  • Phillips S, Szoeke C, South S. Tracking WHO Sustainable Development Goals to improve older Australian's health. Presented at: Australasian Association of Gerontology (AAG); 2020; Melbourne, Victoria. Publisher: AAG.

  • Prada M, Fagnocchi G, Atkins J, Balleste Martinez C, Rossi L. The difference between PICO evaluation across Australia, EU4, and UK [poster]. Presented at: ISPOR Europe 2024; 2024 Nov 10–13; Barcelona, Spain. Poster 144277. Available from: https://www.ispor.org/docs/default-source/euro2024/isporeurope24pradahta47poster144277-pdf.pdf

    Fagnocchi G, Rossi L, Atkins J, Balleste Martinez C, Prada M. The difference between regulatory and market access decisions on treatment availability for ATMPs across Australia, EU4, and UK [poster]. ISPOR Europe 2024; Poster 144201. Available from: https://www.ispor.org/docs/default-source/euro2024/isporeurope24fagnocchihta276poster144201-pdf.pdf

    Rossi L, Fagnocchi G, Atkins J, Balleste Martinez C, Prada M. Early access for innovative medicines in Australia, EU4, and UK [poster]. ISPOR Europe 2024; Poster 144242. Available from: https://www.ispor.org/docs/default-source/euro2024/isporeurope24rossihta290poster144242-pdf.pdf

    Fagnocchi G, Rossi L, Atkins J, Balleste Martinez C, Prada M. The role of real-world data and real-world evidence in Australia, EU4, and UK [poster]. ISPOR Europe 2024; Poster 144267. Available from: https://www.ispor.org/docs/default-source/euro2024/isporeurope24fagnocchirwd14poster144267-pdf.pdf

  • Tilden D, Stynes G, Adams J, Garrett S, Fong L. Quantifying disease severity as a determinant of costs and quality of life in patients with ankylosing spondylitis in Australia [abstract]. ISPOR 7th Annual European Congress; 2004 Oct 24–26; Hamburg, Germany.

    Stynes G, Tilden D, Adams J, Garrett S, Wilson J, Fong L. The burden of ankylosing spondylitis in Australia: an epidemiological and cost of illness model [abstract]. ISPOR 7th Annual European Congress; 2004 Oct 24–26; Hamburg, Germany.

  • Brown S, McGough V, Garrett S, O’Rourke M. Duane’s retraction syndrome Type 1 associated with dissociated vertical deviation: a case report. Aust Orth J. 1992;28:43–46.